1997
DOI: 10.1074/jbc.272.28.17320
|View full text |Cite
|
Sign up to set email alerts
|

Ablation of Goα Overrides G1Restriction Point Control through Ras/ERK/Cyclin D1-CDK Activities

Abstract: We have generated stable IIC9 cell lines, Goa1 and Goa2, that overexpress full-length antisense G o ␣ RNA. As shown previously, expression of antisense G o ␣ RNA ablated the ␣ subunit of the heterotrimeric G protein, G o , resulting in growth in the absence of mitogen. To better understand this change in IIC9 phenotype, we have characterized the signaling pathway and cell cycle events previously shown to be important in control of IIC9 G 1 /S phase progression. In this paper we clearly demonstrate that ablatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
26
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 20 publications
(26 citation statements)
references
References 38 publications
0
26
0
Order By: Relevance
“…Transient Transfection-The cDNA encoding pcDNA3.1 (Invitrogen), ␤-arrestin1 (a kind gift from Marc Caron), ␣-transducin (25), MAS-GRK3-ct (a kind gift from Stephen R. Ikeda), G o ␣C351G, G i2 ␣C352G, and G i3 ␣C351G (generated), carboxyl terminus G␣ peptides (Biotech, Chicago, IL), or xanthine nucleotide-binding G␣ mutants (Guthrie Research Institute, Sayre, PA) were transfected into subconfluent (60 -80%) IIC9 cells using LiptofectAMINE TM (Invitrogen) as previously described (23). The following day, cells were growth-arrested by washing once with ␣-minimal essential medium followed by a 48-h incubation in the same medium prior to agonist stimulation.…”
Section: Methodsmentioning
confidence: 99%
“…Transient Transfection-The cDNA encoding pcDNA3.1 (Invitrogen), ␤-arrestin1 (a kind gift from Marc Caron), ␣-transducin (25), MAS-GRK3-ct (a kind gift from Stephen R. Ikeda), G o ␣C351G, G i2 ␣C352G, and G i3 ␣C351G (generated), carboxyl terminus G␣ peptides (Biotech, Chicago, IL), or xanthine nucleotide-binding G␣ mutants (Guthrie Research Institute, Sayre, PA) were transfected into subconfluent (60 -80%) IIC9 cells using LiptofectAMINE TM (Invitrogen) as previously described (23). The following day, cells were growth-arrested by washing once with ␣-minimal essential medium followed by a 48-h incubation in the same medium prior to agonist stimulation.…”
Section: Methodsmentioning
confidence: 99%
“…Kip1 degradation to ensure the proper activation state of cyclin D1±CDK4 complexes following mitogenic stimulation (265). Interestingly, in thyroid cells where the cAMP is mitogenic, TSH stimulation down-regulates p27…”
Section: Kip1mentioning
confidence: 99%
“…Kip1 degradation have not been de®ned clearly, in Chinese hamster embryo ®broblast cells (IIC9 cells) PDGF stimulation causes the rapid activation of Ras and subsequent downstream activation of ERK (227,265). In addition, Ras also stimulates the downstream activation of the RhoA that regulates p27…”
Section: Kip1mentioning
confidence: 99%
“…Light produced was measured and normalized to transfection efficiency by dividing relative light units by optical density units obtained from ␤-galactosidase activity. ␤-Galactosidase activity was measure as previously described (5).…”
Section: Rbmentioning
confidence: 99%
“…The sequential activation of early G 1 CDK activity, CDK4 or CDK6 together with cyclin D1, D2, or D3, and the late G 1 CDK activity, CDK2 together with cyclin E1 or E2, is believed to be required for progression through G 1 and into S phase. Because IIC9 cells contain CDK4, but not CDK6, and cyclin D1, but not D2 or D3, CDK4-cyclin D1 activation in early G 1 is required for the expression of cyclin E, CDK2 activity, and G 1 -S phase progression (3)(4)(5).…”
mentioning
confidence: 99%